| - | Next-generation NSAIDs for aging-related non communicable inflammatory diseases |
| - | Sex and estrogen signaling via GPER to control PD-L1: implications for slowing inflammaging |
| - | Evidence-based pharmacological and not pharmacological prevention strategies in the elderly |
| - | Inclisiran, statins and monoclonal antibodies anti PCSK9: exploring the elements of differentiation in their pharmacological action |
| - | Exploring the role of enteric nervous system on myelination during early life |
| - | Nutrigenetic approach in the promotion of health in the workplace |
| - | Development of molecular diagnostic systems for health, nutrition and well-being prediction to slow down the aging process |
| - | Pharmacological characterization of Toll-like receptor 4 as a target for opioids in microglia |
| - | Development of innovative therapies for chemotherapy-treated prostate cancer |
| - | Development of senolytics of natural origin for anti-aging therapy |
| - | NOP receptor active structure, transducerome, and biased signaling |
